ABBRITTI, MARTA
 Distribuzione geografica
Continente #
EU - Europa 129
NA - Nord America 81
AS - Asia 29
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 243
Nazione #
US - Stati Uniti d'America 80
IT - Italia 42
IE - Irlanda 28
SE - Svezia 16
GB - Regno Unito 12
DE - Germania 10
PH - Filippine 10
CN - Cina 8
FR - Francia 5
CZ - Repubblica Ceca 4
RU - Federazione Russa 4
SG - Singapore 4
GE - Georgia 3
AT - Austria 2
ES - Italia 2
UA - Ucraina 2
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
CO - Colombia 1
CR - Costa Rica 1
FI - Finlandia 1
GR - Grecia 1
IN - India 1
NG - Nigeria 1
PE - Perù 1
PK - Pakistan 1
Totale 243
Città #
Dublin 27
Chandler 18
Fairfield 14
Pasig 10
Southend 10
Ashburn 9
Florence 9
Lastra a Signa 6
Woodbridge 5
Houston 4
New York 4
Siena 4
Brno 3
Cambridge 3
Jacksonville 3
Moscow 3
Shanghai 3
Singapore 3
Tbilisi 3
Turin 3
Casandrino 2
Messina 2
Milan 2
Málaga 2
Nanjing 2
Naples 2
Princeton 2
Rome 2
Seattle 2
Vienna 2
Ann Arbor 1
Baku 1
Beijing 1
Bogotá 1
Cagliari 1
Dhaka 1
Fremont 1
Fuzhou 1
Helsinki 1
Islamabad 1
Lagos 1
Lima 1
Los Angeles 1
Munich 1
Norwalk 1
Olomouc 1
Pasadena 1
Salerno 1
San José 1
San Mateo 1
Tianjin 1
Totale 185
Nome #
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 136
Immune-Checkpoint Expression on CD4, CD8 and NK Cells in Blood, Bronchoalveolar Lavage and Lymph Nodes of Sarcoidosis 85
T helper and T cytotoxic cells subsets in peripheral, alveolar and lymph nodes of sarcoidosis patients 15
T follicular helper cell subsets in sarcoidosis patients: a comparison between three anatomical compartment 14
Totale 250
Categoria #
all - tutte 920
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 920


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 6 2 2 3 2 5 4 4 4 2 0 2
2020/202120 2 2 2 3 0 1 2 3 1 1 1 2
2021/202220 1 3 3 1 2 0 0 2 1 1 2 4
2022/202353 5 9 4 5 4 9 4 3 4 3 3 0
2023/202493 4 0 1 2 4 14 17 9 4 1 24 13
2024/202517 17 0 0 0 0 0 0 0 0 0 0 0
Totale 250